Fed Regist. 1999 Aug 17;64(158):44653-8.

Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.

[No authors listed]

Abstract

The Food and Drug Administration (FDA) is issuing a final rule establishing that all over-the-counter (OTC) drug products containing colloidal silver ingredients or silver salts for internal or external use are not generally recognized as safe and effective and are misbranded. FDA is issuing this final rule because many OTC drug products containing colloidal silver ingredients or silver salts are being marketed for numerous serious disease conditions and FDA is not aware of any substantial scientific evidence that supports the use of OTC colloidal silver ingredients or silver salts for these disease conditions.

PMID:: 10558603; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Molecular Biology Databases

SILVER, ELEMENTAL - HSDB

Supplemental Content

Related citations

Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule. [Fed Regist. 1999]
Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.
. Fed Regist. 1999 Jan 29; 64(19):4535-40.
Antiperspirant drug products for over-the-counter human use; final monograph. Final rule. [Fed Regist. 2003]
Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS. Fed Regist. 2003 Jun 9; 68(110):34273-93.
Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule. [Fed Regist. 1998]
Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule.
. Fed Regist. 1998 Apr 22; 63(77):19799-802.
Review New OTC drugs and devices 2003: a selective review. [J Am Pharm Assoc (2003). 2004]
Review New OTC drugs and devices 2003: a selective review.
Newton GD, Pray WS, Popovich NG. J Am Pharm Assoc (2003). 2004 Mar-Apr; 44(2):211-25.
Review Prescription to over-the-counter switch: a regulatory perspective. [Clin Ther. 1998]
Review Prescription to over-the-counter switch: a regulatory perspective.
Juhl RP. Clin Ther. 1998; 20 Suppl C:C111-7.

See reviews... See all...

Cited by 1 PubMed Central article

Review An armamentarium of wart treatments. [Clin Med Res. 2006]
Review An armamentarium of wart treatments.
Lipke MM. Clin Med Res. 2006 Dec; 4(4):273-93.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Over-the-counter drug products containing colloidal silver ingredients or silver...
Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
Fed Regist. 1999 Aug 17 ;64(158):44653-8.

PubMed
High alpha-fetoprotein level correlates with high stage, early recurrence and po...
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Int J Cancer. 2004 Oct 20 ;112(1):44-50.

PubMed
Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the r...
Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury.
J Neurosci. 2008 Apr 16 ;28(16):4161-71.

PubMed
Expression of AFP and Rev-Erb A/Rev-Erb B and N-CoR in fetal rat liver, liver in...
Expression of AFP and Rev-Erb A/Rev-Erb B and N-CoR in fetal rat liver, liver injury and liver regeneration.
Comp Hepatol. 2006 Jul 5 ;5:2.

PubMed
Long double-stranded RNA-mediated RNA interference as a tool to achieve site-spe...
Long double-stranded RNA-mediated RNA interference as a tool to achieve site-specific silencing of hypothalamic neuropeptides.
Brain Res Brain Res Protoc. 2004 Jun ;13(2):115-25.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information